HER2-POSITIVE BREAST CARCINOMA
Clinical trials for HER2-POSITIVE BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HER2-POSITIVE BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for HER2-POSITIVE BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a custom vaccine boost breast cancer treatment?
Disease control CompletedThis early-phase study tested a personalized vaccine made from a patient's own immune cells, designed to target HER2-positive breast cancer. 31 adults with stage II or III breast cancer received the vaccine alongside standard chemotherapy before surgery. The goal was to see if th…
Matched conditions: HER2-POSITIVE BREAST CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New combo therapy shows promise in preventing breast cancer return
Disease control CompletedThis study tested a combination of chemotherapy drugs (cyclophosphamide and paclitaxel) plus the targeted therapy trastuzumab given after surgery to 20 patients with early-stage HER2-positive breast cancer. The goal was to see how safe and effective this treatment is at preventin…
Matched conditions: HER2-POSITIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated May 11, 2026 20:46 UTC